title: Can three-times-a-day cyclosporine Neoral avoid cyclosporine toxicity in renal transplant recipients? A pharmacokinetic study.
authors.affiliation: Department of Surgery, University of Cape Town, Cape Town, South Africa.
authors.forename: N
authors.initials: N
authors.lastname: Swart
authors.forename: J
authors.initials: J
authors.lastname: Botha
authors.forename: V
authors.initials: V
authors.lastname: Tandon
authors.forename: P
authors.initials: P
authors.lastname: Michaels
authors.forename: A R
authors.initials: AR
authors.lastname: Pontin
authors.forename: J
authors.initials: J
authors.lastname: Halkett
authors.forename: M D
authors.initials: MD
authors.lastname: Pascoe
authors.forename: D
authors.initials: D
authors.lastname: Kahn
mesh_terms: D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine